Trustmark (TRMK) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Trustmark (TRMK) reported Q3 2025 revenue of $205.15 million, a 4.9% year-over-year increase, and EPS of $0.94, both slightly missing analyst consensus estimates by 0.51% and 1.05% respectively. While Net Interest Margin met expectations and net charge-offs were lower than estimated, the company reported higher-than-expected total nonaccrual loans and nonperforming assets. The stock has underperformed the broader market, declining 2.6% over the past month, and carries a Zacks Rank #4 (Sell), indicating potential near-term underperformance.

Analysis

Trustmark (TRMK) reported Q3 2025 revenue of $205.15 million, a 4.9% year-over-year increase, and EPS of $0.94, up from $0.84 a year ago. Despite year-over-year growth, both figures missed analyst consensus estimates, with revenue falling short by 0.51% and EPS by 1.05%. This slight underperformance against expectations indicates a weaker quarter than anticipated by the market.

Operational metrics presented a mixed picture, with some indicating potential concerns. While Net Interest Margin met the 3.8% estimate and net charge-offs were better than estimated at 0.1% versus 0.2%, several other key metrics underperformed. Total nonaccrual loans ($83.96 million vs. $79.91 million estimated) and total nonperforming assets ($92.28 million vs. $89.28 million estimated) both exceeded analyst projections, suggesting a potential deterioration in asset quality.

Both Net Interest Income ($162.44 million vs. $163.92 million estimated) and Total Noninterest income ($39.93 million vs. $40.48 million estimated) came in below expectations, contributing to the overall revenue miss. The stock's recent performance reflects this, with TRMK returning -2.6% over the past month, significantly underperforming the S&P 500's +3.6% change. The Zacks Rank #4 (Sell) further reinforces a bearish near-term outlook for the stock.

Key Decisions for Investors

• Investors should closely monitor Trustmark's asset quality metrics, particularly the higher-than-expected nonaccrual loans and nonperforming assets, as these could signal future credit risk.
• Given the Q3 earnings miss, underperforming revenue components, and the Zacks Rank #4 (Sell), a cautious stance or re-evaluation of existing positions may be warranted.
• Future guidance on net interest income and strategies to manage nonperforming assets will be critical for assessing the company's ability to reverse recent negative trends.